(S)-4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl[1,4'-bipiperidine]-1'-carboxylatehydrochloride-D10; [1,4’-Bipiperidine]-1’-carboxylic Acid-d10 (4S)-4,11-Diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3’,4’:6,7]indolizino[1,2-b]quinolin-9-yl Ester Hydrochloride; [1,?4'-?Bipiperidine-?2,?2,?3,?3,?4,?4,?5,?5,?6,?6-?d10]?-?1'-?carboxylic Acid (4S)?-?4,?11-?Diethyl-?3,?4,?12,?14-?tetrahydro-?4-?hydroxy-?3,?14-?dioxo-?1H-?pyrano[3',?4':6,?7]?indolizino[1,?2-?b]?quinolin-?9-?yl Ester Monohydrochloride
Irinotecan-d10 HCl is a fully characterized chemical compound used as a reference standard of API Irinotecan. The standard offered is compliant with regulatory guidelines. Irinotecan-d10 HCl is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 718612-62-5
Related products
Irinotecan EP Impurity L HCl (R-Irinotecan HCl)
M.F.
M.W. 586.69 36.46
CAT# AR-I01717
CAS# 1992961-26-8
Irinotecan EP Impurity E ((S)-7-Ethyl-10-Hydroxy Camptothecin)
M.F.
M.W. 392.40
CAT# AR-I01722
CAS# 86639-52-3
